Babiker Tarig, Chakera Ali J, Shepherd Maggie, Hattersley Andrew T
Department of Diabetes and Endocrinology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
BMC Endocr Disord. 2014 Jun 9;14:45. doi: 10.1186/1472-6823-14-45.
11 patients were referred to our Molecular Genetics Department at the Royal Devon and Exeter Hospital between 2000-2012 with a physician's diagnosis of remitting diabetes. Our aim was to identify patients with remitting diabetes whose clinical presentation is not explained by any known aetiology of diabetes.
We obtained longitudinal clinical data on all 11 patients from the hospital records. All patients were aged between 0.5 and 35 years at diagnosis. We applied clinical criteria derived from the literature to establish 1) definite diabetes, 2) diabetes initially severe-requiring treatment with insulin, 3) remission of diabetes, and 4) exclusion of known causes of remitting diabetes.
10 out of 11 patients had an alternative explanation for their remission or a clear diagnosis was not identified. We identified a single patient with idiopathic remitting diabetes using these criteria. The patient was a white Caucasian female diagnosed aged 15 with symptoms of diabetes, laboratory glucose of 21.2 mmol/L and HbA1c 134 mmol/mol. Her BMI was 23.6 kg/m2. She was treated with basal bolus insulin but discontinued two years after diagnosis due to hypoglycaemia. 13 years post diagnosis, she had a normal oral glucose tolerance test during pregnancy (fasting glucose 4.5 mmol/L, 2 hr glucose 4.8 mmol/L) and an HbA1c of 30 mmol/mol. This patient does not appear to have Type 1 or Type 2 diabetes, and furthermore does not fit into current classifications of diabetes.
Idiopathic remitting diabetes is rare but does exist. Strict clinical criteria are important to ensure patients have a robust clinical diagnosis. Identification of more patients with idiopathic remitting diabetes will enable further study of the clinical course of this syndrome. Applying these strict criteria will allow the identification of patients with remitting diabetes to assess its aetiology.
2000年至2012年间,11名被内科医生诊断为缓解期糖尿病的患者被转诊至皇家德文郡和埃克塞特医院分子遗传学部。我们的目的是识别那些缓解期糖尿病患者,其临床表现无法用任何已知的糖尿病病因来解释。
我们从医院记录中获取了所有11名患者的纵向临床数据。所有患者确诊时年龄在0.5岁至35岁之间。我们应用从文献中得出的临床标准来确定:1)确诊糖尿病;2)初发时病情严重需用胰岛素治疗的糖尿病;3)糖尿病缓解;4)排除已知的缓解期糖尿病病因。
11名患者中有10名的病情缓解存在其他解释,或者未明确诊断。使用这些标准,我们识别出1例特发性缓解期糖尿病患者。该患者为白种人女性,15岁确诊,有糖尿病症状,实验室血糖为21.2毫摩尔/升,糖化血红蛋白为134毫摩尔/摩尔。她的体重指数为23.6千克/平方米。她接受了基础加餐时胰岛素治疗,但因低血糖在确诊后两年停药。确诊13年后,她在孕期口服葡萄糖耐量试验正常(空腹血糖4.5毫摩尔/升,餐后2小时血糖4.8毫摩尔/升),糖化血红蛋白为30毫摩尔/摩尔。该患者似乎既不是1型糖尿病也不是2型糖尿病,而且不符合目前的糖尿病分类。
特发性缓解期糖尿病很罕见,但确实存在。严格的临床标准对于确保患者获得可靠的临床诊断很重要。识别更多特发性缓解期糖尿病患者将有助于进一步研究该综合征的临床病程。应用这些严格标准将有助于识别缓解期糖尿病患者以评估其病因。